If you’ve built something with AI — a model, a tool, a platform, an algorithm — you’re probably wondering whether you can license it. The short answer is yes. But there are a few things about AI licensing that work differently than licensing a traditional patent or product, and if you don’t understand them going in, you can make mistakes that cost you leverage, revenue, or both.
I’ve spent 35 years licensing technology across industries — medical devices, entertainment, consumer products, food processing, digital platforms. I’ve watched AI go from a niche research topic to the centerpiece of every licensing conversation I have. So let me break down what’s actually changed, what hasn’t, and what you need to know before you approach a potential licensing partner with your AI innovation.
What Hasn’t Changed: The Core Licensing Logic Still Applies
Let’s start here, because a lot of AI innovators overthink this.
The fundamental deal structure of a licensing agreement is the same whether you’re licensing a patented manufacturing process from 1989 or a machine learning model from last year. You have IP. Someone else wants to use it. You grant them rights in exchange for compensation — usually royalties, sometimes an upfront fee, sometimes both.
What you’re negotiating is still:
- Scope — what they can use it for, in what markets, in what territories
- Exclusivity — whether they’re the only one who gets it, or one of several
- Duration — how long the agreement lasts
- Compensation — royalty rate, minimum guarantees, upfront fees
- Performance milestones — what they’re required to do with it
- Reversion rights — what happens if they don’t perform
None of that changes because your IP happens to involve artificial intelligence. The business logic of licensing is durable. What changes is how you protect it, how you position it, and how you handle some tricky new questions about ownership and improvement.
What Is Different: The Four AI-Specific Licensing Challenges
1. Patent Protection Is Murkier for AI
Traditional inventions are relatively straightforward to patent — a device, a process, a composition of matter. AI innovations occupy grayer territory.
The USPTO has been actively clarifying its position on AI-assisted inventions, and as of late 2025, the guidance has been moving in a more favorable direction for innovators. But the core challenge remains: software-based and AI-driven inventions still face more scrutiny on patent eligibility than hardware inventions do.
This matters for licensing because your leverage in any negotiation is directly tied to the strength and enforceability of your IP protection. A well-drafted patent gives you something concrete to license. A trade secret or proprietary dataset is licensable too — but it requires different deal structures and much tighter confidentiality provisions.
What to do: Before you approach anyone, get a clear picture of what you can protect and how. That means working with a patent attorney who understands both the technology and the current USPTO guidance on AI. Don’t go into a licensing conversation without knowing exactly what you own and how it’s protected.
2. Ownership Gets Complicated When AI Is Involved in Creation
Here’s a question that’s tripping up a lot of innovators right now: if AI helped create your innovation, who owns it?
The current U.S. legal position is that AI cannot be an inventor — a human must be named. But the real-world question is more nuanced. If your team used AI tools to generate or refine the core innovation, you need to document clearly who contributed what, and ensure your ownership chain is clean.
This matters especially when you’re licensing to a larger company. Their legal team will do due diligence. If there are questions about whether your IP is cleanly owned — by you, not split with a former employer, an AI platform, or a collaborator who wasn’t properly handled — that can kill a deal or dramatically reduce your leverage.
What to do: Document your development process. Keep records of who built what. Make sure any AI tools you used are properly accounted for in terms of their terms of service and your ownership rights over outputs.
3. The “Improvement” Problem Is Bigger with AI
In traditional licensing, improvement clauses govern what happens when a licensee improves on your technology. With AI, this gets thornier.
Your licensee will likely fine-tune your model, retrain it on their data, or build proprietary layers on top of it. The question of who owns those improvements — and whether they feed back into your core model — is one of the most negotiated points in any AI licensing deal today.
If you don’t address this carefully upfront, you can end up in a situation where your licensee has effectively built something substantially better than what you licensed them, using your foundation, and you have no claim to it.
What to do: Define clearly in the agreement what constitutes an “improvement” versus a “derivative work.” Negotiate for grant-back rights — the right to license back any improvements they make — especially if you’re doing a non-exclusive deal with multiple licensees.
4. Data Is Often as Valuable as the Model Itself
In many AI licensing deals, the trained model and the underlying dataset are both licensable assets — and sometimes the data is actually more valuable to the licensee than the model.
If you’ve assembled a proprietary dataset that trained your model, that dataset may be independently licensable. It may also be something you want to keep control of even as you license the model. How you structure access to the data, how you handle updates to the model as new data comes in, and whether the licensee gets access to future training data — all of these are negotiating points that don’t exist in traditional technology licensing.
What to do: Separate your assets before you go to market. Identify what you have: the algorithm, the trained model, the dataset, the interface, the integration methodology. Each can be licensed independently or bundled. Understanding your full asset picture gives you more flexibility and more leverage.
How to Position Your AI Innovation for Licensing
The biggest mistake AI innovators make when approaching licensees is leading with the technology instead of the outcome.
Nobody licenses a machine learning model. They license faster fraud detection, reduced diagnostic errors, higher customer retention, lower operational costs. Your job in any licensing pitch is to translate your technology into a business result that a specific type of company cares about.
This is where your cross-industry opportunity is biggest. An AI model built for one industry often has direct applications in two or three others. A computer vision system built for manufacturing quality control can be licensed to food safety inspection, medical imaging analysis, and retail inventory management — often with minimal modification.
Before you pitch to anyone, map out:
- What problem does this solve? In plain language, not technical language.
- What industries have this problem? More than you probably think.
- What does solving this problem worth to a company? In revenue terms, cost savings, risk reduction.
- What’s your evidence it works? Data, case studies, pilot results, third-party validation.
That framing — problem, market, value, proof — is your licensing pitch. The technology is what gets you in the door. The business case is what gets you a deal.
Royalty Structures for AI Licensing
AI licensing deals are using some newer compensation structures alongside the traditional royalty model. Here’s what you’ll likely encounter:
Usage-Based Royalties — Instead of a percentage of net sales, the licensee pays based on how much they use your model. Per API call, per query, per prediction. This works well when the value of your AI is tied to volume of use rather than a product sale.
Revenue Share — A percentage of the incremental revenue the licensee generates using your AI. This is increasingly common in fintech and health tech licensing where the AI directly drives measurable revenue outcomes.
Subscription / SaaS Hybrid — A flat monthly or annual license fee, often combined with a usage cap. Common when the licensee wants predictable costs and you want predictable revenue.
Traditional Royalty on Net Sales — Still common, especially when the AI is embedded in a product that gets sold. Typically in the 3%–8% range for technology licensing, though AI innovations with strong differentiation can command the top of that range and beyond.
Minimum Annual Guarantees — Whatever structure you use, push for a minimum annual payment. This ensures you’re getting real revenue even if the licensee underperforms, and it gives them a financial incentive to actually deploy and use your technology.
The Bottom Line
Licensing an AI innovation is absolutely viable — and in many cases, it’s the smartest path to commercialization. You avoid the capital requirements of building a company around it, you can reach multiple markets simultaneously through multiple licensees, and you keep ownership of the underlying IP.
What you need to get right is the foundation: clean IP ownership, appropriate protection, a clear picture of your full asset stack, and a business-focused pitch that translates your technology into outcomes a potential licensee cares about.
Get those right, and the deal structure itself isn’t that different from any other technology licensing deal. That’s actually good news — it means 35 years of licensing experience is still directly applicable, even in a world where the technology is brand new.
Ready to explore whether your AI innovation is licensing-ready? Schedule a free 15-minute strategy call and let’s take a look at what you’ve built and where it fits in the market.
Want more insights on licensing strategy? Subscribe to the LCG newsletter for monthly updates on licensing trends, deal strategies, and commercialization opportunities.
Rand Brenner is an IP professional whose passion is helping inventors, startups, and businesses use licensing to turn their IP into income-producing products, services, and technologies. His decades of experience run the gamut from medical devices to food technology to consumer products. He’s licensed some of the biggest Hollywood entertainment blockbusters, including the Batman Movies (1 and 2) and the number one kid’s action TV show, the Mighty Morphin Power Rangers. Rand speaks about licensing and is a featured speaker at investment conferences, trade shows, colleges, and startup events. His first book, Hidden Wealth: The Money-Making Power of Licensing, was released in 2019 and is available on Amazon.com. He’s also a published writer, and his articles have appeared in several prestigious trade magazines, including The Licensing Journal, Intellectual Property Magazine, and License India.
Working Through a Licensing or Commercialization Challenge?
If you have market-ready intellectual property, a licensing campaign that has stalled, or a business opportunity that may benefit from licensing, a short strategy discussion can help clarify the next step.